
Story of 2021: The War on Treatment That Killed Millions | Guest: Dr. Tess Lawrie | 12/17/21
Conservative Review with Daniel Horowitz
00:00
Ivomecton Is All Am
Ibemectan has been the subject of a major trial at Oxford University. The drug is being trialled in patients with an aggressive form of bowel cancer called acute myeloid leukemia (AML) But doctors have raised concerns about its safety and effectiveness. And now they've found out that it could be used to treat other forms of AML as well, says Dr Andrew Wakefield.
Play episode from 41:07
Transcript


